Side Effects of COVID-19 Vaccines in Iraqi Kurdistan: A Population-Based Study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Most COVID-19 vaccine recipients experienced mild side effects, with Oxford/AstraZeneca showing more than Pfizer/BioNTech and Sinopharm. These findings aim to increase vaccine confidence.
Area Of Science
- Immunology
- Public Health
- Epidemiology
Background
- The COVID-19 pandemic necessitated rapid vaccine development.
- Vaccine hesitancy due to safety concerns remains a global challenge.
- Understanding vaccine side effect profiles is crucial for public trust.
Purpose Of The Study
- To compare side effects of Pfizer/BioNTech, Oxford/AstraZeneca, and Sinopharm vaccines.
- To identify factors associated with post-vaccination side effects in Iraqi Kurdistan.
Main Methods
- A population-based study involving 1,340 participants in Iraqi Kurdistan (September 2022 - April 2023).
- Data collected via face-to-face interviews and online forms, including demographics, vaccination status, and side effects.
- Statistical analysis to compare side effect frequencies and identify associated factors.
Main Results
- 76.94% reported side effects, averaging 2.8 days; 60% had no or mild reactions.
- Common side effects: injection site pain, fever, headache, fatigue.
- Oxford/AstraZeneca showed higher side effect frequency than Pfizer/BioNTech and Sinopharm (p=0.001).
Conclusions
- Most COVID-19 vaccine side effects are mild and transient.
- Findings support vaccine safety and can help increase uptake, particularly booster doses.
- Demographic and health factors influence side effect occurrence.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Overview
Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
Overview
The ability of a single antibody to recognize multiple structurally similar epitopes is an important immune defense strategy that enables the host to efficiently defend against many potentially threatening pathogens. However, cross-reactivity also elicits allergy symptoms against related allergens. It is increasingly important to understand the principles of cross-reactivity, as antibodies are actively being developed as therapeutic modalities for diverse diseases, including cancer.
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...